{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T23:47:04Z","timestamp":1793490424793,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DP190100499"],"award-info":[{"award-number":["DP190100499"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003354","name":"Garnett Passe and Rodney Williams Memorial Foundation","doi-asserted-by":"publisher","award":["2025_CG_Sinha_Perry_12622"],"award-info":[{"award-number":["2025_CG_Sinha_Perry_12622"]}],"id":[{"id":"10.13039\/501100003354","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001793","name":"Queensland University of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1173927"],"award-info":[{"award-number":["APP1173927"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.redox.2025.103989","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T07:26:01Z","timestamp":1766215561000},"page":"103989","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Redox-active nitroxides enhance cisplatin efficacy against cervical cancer"],"prefix":"10.1016","volume":"89","author":[{"given":"Carl P.","family":"Soltau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debottam","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshita P.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Moseley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassie L.","family":"Rayner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel L.","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek J.","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"Bottle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian H.","family":"Frazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7211-0477","authenticated-orcid":false,"given":"Alexander P.","family":"Martyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2025.103989_bib1","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/S2214-109X(22)00501-0","article-title":"Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO global cervical cancer elimination initiative","volume":"11","author":"Singh","year":"2023","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.redox.2025.103989_bib2","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1080\/01443615.2019.1634030","article-title":"Human papillomavirus and cervical cancer","volume":"40","author":"Okunade","year":"2020","journal-title":"J. Obstet. Gynaecol."},{"key":"10.1016\/j.redox.2025.103989_bib3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nri1260","article-title":"Prevention of cervical cancer through papillomavirus vaccination","volume":"4","author":"Frazer","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.redox.2025.103989_bib4","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1021\/acsptsci.9b00032","article-title":"The HPV vaccine story","volume":"2","author":"Frazer","year":"2019","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.redox.2025.103989_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","article-title":"Cervical cancer","volume":"393","author":"Cohen","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.redox.2025.103989_bib6","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.redox.2025.103989_bib7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12032-023-01997-9","article-title":"Molecular mechanisms augmenting resistance to current therapies in clinics among cervical cancer patients","volume":"40","author":"Das","year":"2023","journal-title":"Med. Oncol."},{"key":"10.1016\/j.redox.2025.103989_bib8","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.2147\/DDDT.S106412","article-title":"Molecular mechanisms of cisplatin resistance in cervical cancer","volume":"10","author":"Zhu","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.redox.2025.103989_bib9","first-page":"3437","article-title":"Overexpression of glucocorticoid receptor promotes the poor progression and induces cisplatin resistance through p38 MAP kinase in cervical cancer patients","volume":"12","author":"Han","year":"2022","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.redox.2025.103989_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/574659","article-title":"Cellular levels of oxidative stress affect the response of cervical cancer cells to chemotherapeutic agents","volume":"2014","author":"Filippova","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.redox.2025.103989_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081162","article-title":"Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions","volume":"8","author":"Marullo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.redox.2025.103989_bib12","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.freeradbiomed.2016.03.006","article-title":"Platinum anti-cancer drugs: free radical mechanism of Pt-DNA adduct formation and anti-neoplastic effect","volume":"95","author":"Fong","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2025.103989_bib13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cbi.2004.03.001","article-title":"Cisplatin-evoked DNA fragmentation in normal and cancer cells and its modulation by free radical scavengers and the tyrosine kinase inhibitor STI571","volume":"147","author":"Wozniak","year":"2004","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.redox.2025.103989_bib14","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejphar.2011.06.051","article-title":"Abrogation of cisplatin-induced nephrotoxicity in mice by alpha lipoic acid through ameliorating oxidative stress and enhancing gene expression of antioxidant enzymes","volume":"668","author":"El-Beshbishy","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.redox.2025.103989_bib15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s12013-016-0759-0","article-title":"Biological relevance of free radicals and nitroxides","volume":"75","author":"Prescott","year":"2017","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.redox.2025.103989_bib16","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.freeradbiomed.2007.02.030","article-title":"The chemistry and biology of nitroxide compounds","volume":"42","author":"Soule","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2025.103989_bib17","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1007\/s11064-023-03978-w","article-title":"Preserving retinal structure and function with the novel nitroxide antioxidant","volume":"48","author":"Rayner","year":"2023","journal-title":"DCTEIO, Neurochem. Res."},{"key":"10.1016\/j.redox.2025.103989_bib18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/978-3-031-76550-6_81","article-title":"Steroid-nitroxide hybrid compound protects the retina in a model of CNV","volume":"1468","author":"Toto","year":"2025","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.redox.2025.103989_bib19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pharmthera.2010.01.003","article-title":"Effects of tempol and redox-cycling nitroxides in models of oxidative stress","volume":"126","author":"Wilcox","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.redox.2025.103989_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112490","article-title":"Nitroxides as antioxidants and anticancer drugs","volume":"18","author":"Lewandowski","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2025.103989_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6235641","article-title":"Redox homeostasis and cellular antioxidant systems: crucial players in cancer growth and therapy","volume":"2016","author":"Marengo","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.redox.2025.103989_bib22","doi-asserted-by":"crossref","first-page":"707","DOI":"10.4161\/cbt.12.8.16441","article-title":"Mitochondria-targeted nitroxides exacerbate fluvastatin-mediated cytostatic and cytotoxic effects in breast cancer cells","volume":"12","author":"Cheng","year":"2011","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.redox.2025.103989_bib23","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/CAD.0b013e32836442c6","article-title":"Mitochondria-targeted antioxidant and glycolysis inhibition: synergistic therapy in hepatocellular carcinoma","volume":"24","author":"Dilip","year":"2013","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.redox.2025.103989_bib24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cbi.2012.06.001","article-title":"Anticancer effect of tert-butyl-2(4,5-dihydrogen-4,4,5,5-tetramethyl-3-O-1H-imidazole-3-cationic-1-oxyl-2)-pyrrolidine-1-carboxylic ester on human hepatoma HepG2 cell line","volume":"199","author":"Guo","year":"2012","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.redox.2025.103989_bib25","first-page":"1271","article-title":"Synthesis of a novel adamantyl nitroxide derivative with potent anti-hepatoma activity in vitro and in vivo","volume":"6","author":"Sun","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.redox.2025.103989_bib26","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0891-5849(00)00347-6","article-title":"The nitroxide tempol induces oxidative stress, p21(WAF1\/CIP1), and cell death in HL60 cells","volume":"29","author":"Gariboldi","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2025.103989_bib27","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.1016\/j.bmc.2014.09.035","article-title":"Design and synthesis of novel spin-labeled camptothecin derivatives as potent cytotoxic agents","volume":"22","author":"Zhao","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.redox.2025.103989_bib28","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1007\/s00044-013-0906-8","article-title":"Synthesis of novel spin-labeled derivatives of 5-FU as potential antineoplastic agents","volume":"23","author":"Yang","year":"2014","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.redox.2025.103989_bib29","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.freeradbiomed.2010.02.009","article-title":"Safe and targeted anticancer efficacy of a novel class of antioxidant-conjugated difluorodiarylidenyl piperidones: differential cytotoxicity in healthy and cancer cells","volume":"48","author":"Selvendiran","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2025.103989_bib30","first-page":"385","article-title":"Platinum complexes with bioactive nitroxyl radicals: Synthesis and antitumor properties, nitroxides-theory, experiment and applications","author":"Sen","year":"2012","journal-title":"IntechOpen"},{"key":"10.1016\/j.redox.2025.103989_bib31","first-page":"4847","article-title":"Piperidine nitroxide tempol enhances cisplatin-induced apoptosis in ovarian cancer cells","volume":"16","author":"Wang","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.redox.2025.103989_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108889","article-title":"Tempol, a superoxide dismutase mimetic agent, ameliorates cisplatin-induced nephrotoxicity through alleviation of mitochondrial dysfunction in mice","volume":"9","author":"Ahmed","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.redox.2025.103989_bib33","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.freeradbiomed.2021.10.032","article-title":"Cisplatin induces lung cell cilia disruption and lung damage via oxidative stress","volume":"177","author":"Han","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2025.103989_bib34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.prro.2022.07.003","article-title":"Use of glucocorticoids in patients with cancer: potential benefits, harms, and practical considerations for clinical practice","volume":"13","author":"Kim","year":"2023","journal-title":"Pract. Radiat. Oncol."},{"key":"10.1016\/j.redox.2025.103989_bib35","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/978-1-4939-2895-8_14","article-title":"Glucocorticoids and cancer","volume":"872","author":"Pufall","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.redox.2025.103989_bib36","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.3748\/wjg.v11.i40.6373","article-title":"Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors","volume":"11","author":"Lu","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.redox.2025.103989_bib37","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1677\/joe.1.06453","article-title":"Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-kappaB activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa","volume":"188","author":"Lu","year":"2006","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.redox.2025.103989_bib38","first-page":"3289","article-title":"Synthesis of anti-oxidant steroids by hybridisation with nitroxides","volume":"56","author":"Soltau","year":"2023","journal-title":"Synthesis"},{"key":"10.1016\/j.redox.2025.103989_bib39","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.2174\/092986707781058805","article-title":"Molecular hybridization: a useful tool in the design of new drug prototypes","volume":"14","author":"Viegas-Junior","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.redox.2025.103989_bib40","doi-asserted-by":"crossref","first-page":"11958","DOI":"10.1021\/acs.jmedchem.1c00541","article-title":"Development of novel glucocorticoids for use in antibody-drug conjugates for the treatment of inflammatory diseases","volume":"64","author":"Han","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.redox.2025.103989_bib41","doi-asserted-by":"crossref","first-page":"10416","DOI":"10.1039\/D2CC04024G","article-title":"Reactions of sulfoxides with reactive oxygen species to reveal the radical chemistry of pollution-derived particulate matter","volume":"58","author":"Soltau","year":"2022","journal-title":"Chem. Commun."},{"key":"10.1016\/j.redox.2025.103989_bib42","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1021\/jo801099w","article-title":"Experimental and theoretical studies of the redox potentials of cyclic nitroxides","volume":"73","author":"Blinco","year":"2008","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.redox.2025.103989_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25031446","article-title":"The cellular and organismal effects of nitroxides and nitroxide-containing nanoparticles","volume":"25","author":"Sadowska-Bartosz","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2025.103989_bib44","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1093\/bioinformatics\/btx162","article-title":"SynergyFinder: a web application for analyzing drug combination dose-response matrix data","volume":"33","author":"Ianevski","year":"2017","journal-title":"Bioinformatics"},{"key":"10.1016\/j.redox.2025.103989_bib45","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.csbj.2015.09.001","article-title":"Searching for drug synergy in complex dose-response landscapes using an interaction potency model","volume":"13","author":"Yadav","year":"2015","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.redox.2025.103989_bib46","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","article-title":"ROS in cancer therapy: the bright side of the moon","volume":"52","author":"Perillo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.redox.2025.103989_bib47","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00404-018-4928-9","article-title":"Glucocorticoid receptor in cervical cancer: an immunhistochemical analysis","volume":"299","author":"Kost","year":"2019","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.redox.2025.103989_bib48","first-page":"340","article-title":"A comprehensive review on steroidal bioconjugates as promising leads in drug discovery, ACS bio","volume":"2","author":"Bansal","year":"2022","journal-title":"Med. Chem. Au"},{"key":"10.1016\/j.redox.2025.103989_bib49","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/jps.2600751013","article-title":"Glucocorticoids: binding affinity and lipophilicity","volume":"75","author":"Ponec","year":"1986","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.redox.2025.103989_bib50","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0378-4347(91)80373-K","article-title":"Assay methodology for prednisolone, prednisolone acetate and prednisolone sodium phosphate in rabbit aqueous humor and ocular physiological solutions","volume":"565","author":"Musson","year":"1991","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.redox.2025.103989_bib51","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000056347","article-title":"Distribution of hydrolytic activity catalyzes the biotransformation of prednisolone 21-acetate in human skin","volume":"14","author":"Hikima","year":"2001","journal-title":"Skin Pharmacol. Appl. Skin Physiol."},{"key":"10.1016\/j.redox.2025.103989_bib52","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0022-4731(77)90187-X","article-title":"Structure-activity relationships for glucocorticoids-I. Determination of receptor binding and biological activity","volume":"8","author":"Rousseau","year":"1977","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.redox.2025.103989_bib53","first-page":"260","article-title":"The hydrolysis of prednimustine by enzymes from normal and tumour tissues","volume":"420","author":"Wilkinson","year":"1978","journal-title":"J. Excerpta. Med. Int. Congr. Ser."},{"key":"10.1016\/j.redox.2025.103989_bib54","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0014-2964(77)90143-8","article-title":"Studies on the toxicity and antitumour activity of prednimustine, a prednisolone ester of chlorambucil","volume":"13","author":"Harrap","year":"1977","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.redox.2025.103989_bib55","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S0891-5849(03)00306-X","article-title":"Pro-oxidative activity of nitroxides in their reactions with glutathione","volume":"35","author":"Glebska","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2025.103989_bib56","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0304-4165(84)90038-2","article-title":"Superoxide-dependent reduction of nitroxides by thiols","volume":"802","author":"Finkelstein","year":"1984","journal-title":"Biochim. Biophys. Acta \u2013 Gen. Subj."},{"key":"10.1016\/j.redox.2025.103989_bib57","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.4252\/wjsc.v12.i11.1410","article-title":"Glutathione metabolism is essential for self-renewal and chemoresistance of pancreatic cancer stem cells","volume":"12","author":"Jagust","year":"2020","journal-title":"World J. Stem Cells"},{"key":"10.1016\/j.redox.2025.103989_bib58","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/972913","article-title":"Role of glutathione in cancer progression and chemoresistance","volume":"2013","author":"Traverso","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.redox.2025.103989_bib59","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1158\/1078-0432.CCR-12-1424","article-title":"Molecular pathways: reactive oxygen species homeostasis in cancer cells and implications for cancer therapy","volume":"19","author":"Nogueira","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.redox.2025.103989_bib60","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/bjc.1994.55","article-title":"Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro","volume":"69","author":"Jekunen","year":"1994","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.redox.2025.103989_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061451","article-title":"Mechanisms of chemotherapy-induced peripheral neuropathy","volume":"20","author":"Zajaczkowska","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.redox.2025.103989_bib62","first-page":"2345","article-title":"Paclitaxel plus cisplatin vs. 5-fluorouracil plus cisplatin as first-line treatment for patients with advanced squamous cell esophageal cancer","volume":"6","author":"Liu","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.redox.2025.103989_bib63","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1081\/CNV-120002489","article-title":"Phase I study of sequential administration of topotecan and 5-fluorouracil in patients with advanced malignancies","volume":"20","author":"Sbar","year":"2002","journal-title":"Cancer Invest."},{"key":"10.1016\/j.redox.2025.103989_bib64","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/ejoc.201201551","article-title":"Approaches to the synthesis of a water\u2010soluble carboxy nitroxide","volume":"2013","author":"Thomas","year":"2013","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.redox.2025.103989_bib65","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s42003-020-01304-6","article-title":"Cep55 overexpression promotes genomic instability and tumorigenesis in mice","volume":"3","author":"Sinha","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.redox.2025.103989_bib66","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ijc.32410","article-title":"Therapeutic cooperation between auranofin, a thioredoxin reductase inhibitor and anti-PD-L1 antibody for treatment of triple-negative breast cancer","volume":"146","author":"Raninga","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.redox.2025.103989_bib67","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708566","article-title":"CEP55 is a determinant of cell fate during perturbed mitosis in breast cancer","volume":"10","author":"Kalimutho","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.redox.2025.103989_bib68","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.redox.2025.103989_bib69","doi-asserted-by":"crossref","first-page":"W739","DOI":"10.1093\/nar\/gkac382","article-title":"SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples","volume":"50","author":"Ianevski","year":"2022","journal-title":"Nucleic Acids Res."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231725005026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231725005026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:06:41Z","timestamp":1778854001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231725005026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":69,"alternative-id":["S2213231725005026"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2025.103989","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Redox-active nitroxides enhance cisplatin efficacy against cervical cancer","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2025.103989","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103989"}}